4.3 Review

The role of N-glycans in colorectal cancer progression: Potential biomarkers and therapeutic applications

Journal

ONCOTARGET
Volume 7, Issue 15, Pages 19395-19413

Publisher

IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.6283

Keywords

N-glycans; colorectal cancer; biomarkers; glycosylation; carcinoma

Funding

  1. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
  2. Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [23038.002288/2013-58]
  3. Ministerio da Saude
  4. Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado de Rio de Janeiro (FAPERJ) [E-26/112.090/2013]
  5. Instituto Nacional de Ciencia e Tecnologia em Cancer [573806/2008-0, 170.026/2008]

Ask authors/readers for more resources

Changes in glycosylation, which is one of the most common protein post-translational modifications, are considered to be a hallmark of cancer. N-glycans can modulate cell migration, cell-cell adhesion, cell signaling, growth and metastasis. The colorectal cancer (CRC) is a leading cause of cancer-related mortality and the correlation between CRC progression and changes in the pattern of expression of N-glycans is being considered in the search for new biomarkers. Here, we review the role of N-glycans in CRC cell biology. The perspectives on emerging N-glycan-related anticancer therapies, along with new insights and challenges, are also discussed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available